EquitiesMar 30 2017

Dalton buys alternatives firm MSK

twitter-iconfacebook-iconlinkedin-iconmail-iconprint-icon
Search supported by
Dalton buys alternatives firm MSK

Boutique asset manager Dalton Strategic Partnership (DSP) is to acquire alternatives specialist MSK Capital Partners.

The acquisition of MSK, which currently manages around $230m (£184m) in global equity long/short portfolios, forms part of Dalton's long-term growth plan to expand its product offering, particularly in the liquid absolute return space.

MSK will continue to market its funds under the original branding but the investment team, led by Makis Kaketsis, will be embedded in Dalton's wider investment teams.

Wence von Liechtenstein (pictured), chief executive at Dalton, said: "This is an important step forward in the development of DSP. Makis and his team have a very strong investment process, a shared vision and are a close cultural fit."

Mr Kaketsis added: "We have known DSP for many years and are certain that our two businesses are highly complementary."

Last year Investment Adviser reported that Dalton, which had some $1.8bn in assets under management at the end of February 2017, had soft-closed its pair of European long/short funds as money continued to flood into absolute return offerings.